NVDA
66
-2
DTE
43
10
MET
54
4
DD
48
3
DIS
41
2
MRK
56
-7
CF
36
3
PFG
37
3
QCOM
82
3
ADM
30
2
NAVI
22
-11
TRV
42
3
HAL
29
3
ROP
71
2
COST
74
2
URBN
70
14
NWSA
71
-4
TAP
31
2
L
67
15
RF
37
2
NVDA
66
-2
DTE
43
10
MET
54
4
DD
48
3
DIS
41
2
MRK
56
-7
CF
36
3
PFG
37
3
QCOM
82
3
ADM
30
2
NAVI
22
-11
TRV
42
3
HAL
29
3
ROP
71
2
COST
74
2
URBN
70
14
NWSA
71
-4
TAP
31
2
L
67
15
RF
37
2
Financhill
Back

XPEL Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
45

XPEL
XPEL

Last Price:
38.5300
Seasonality Move:
56.04%
Sell
41

RARE
Ultragenyx Pharmaceutical

Last Price:
39.79
Seasonality Move:
3.65%
Sell
45
XPEL (XPEL) is a Sell

Is XPEL a Buy, Sell or Hold?

  • The current XPEL [XPEL] share price is $38.4500. The Score for XPEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • XPEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.80. The Score for RARE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XPEL Stock Price Chart

What is XPEL's stock price today?

  • The XPEL share price today is $38.4500
    The current trend is relatively stagnant and XPEL is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

XPEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 47.64 Sell
Chaikin Money Flow: 118295 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.6572 - 39.0372) Buy
Bollinger Bands (100): (39.313 - 56.653) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 44 Sell
Chaikin Money Flow: 896649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.57 - 42.35) Sell
Bollinger Bands (100): (41.42 - 48.86) Sell

XPEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.03 Sell
20-day SMA: 37.46 Buy
50-day SMA: 42.81 Sell
200-day SMA: 53.08 Sell
8-day EMA: 38.61 Sell
20-day EMA: 38.45 Sell
50-day EMA: 41.61 Sell
200-day EMA: 52.2 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.65 Sell
20-day SMA: 40.82 Sell
50-day SMA: 42.69 Sell
200-day SMA: 42.45 Sell
8-day EMA: 41.15 Sell
20-day EMA: 41.29 Sell
50-day EMA: 42.49 Sell
200-day EMA: 43.61 Sell

XPEL Earnings Growth & XPEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.03 per share, an increase this year of $0.84 per share, and an increase next year of $1.07 per share.

XPEL Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):